---
title: "Astera's Q2 results draw positive reactions from analysts for Scorpio X lineup"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294972598.md"
description: "Astera Labs (ALAB) reported Q2 results that beat estimates, with analysts highlighting the positive reception of its new Scorpio X product line. Susquehanna raised its price target to $310 from $275, maintaining a Neutral rating. Despite the positive analyst sentiment, shares remained largely flat in premarket trading."
datetime: "2026-08-05T13:05:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294972598.md)
  - [en](https://longbridge.com/en/news/294972598.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294972598.md)
---

# Astera's Q2 results draw positive reactions from analysts for Scorpio X lineup

Astera Labs (ALAB) second quarter results beat estimates, and analysts highlighted positives from the new product line Scorpio X. Shares of Astera Labs were largely flat premarket on Wednesday. Susquehanna increased its price target on Astera's stock to $310 from $275 while keeping a Neutral rating. "Reported 2Q26 revenue/EPS of $392 million/$0.80 ...

### Related Stocks

- [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md)
- [LABX.US](https://longbridge.com/en/quote/LABX.US.md)

## Related News & Research

- [ALAB: Record Q2 revenue and Scorpio X-Series ramp drive strong growth outlook for Q3](https://longbridge.com/en/news/294883659.md)
- [Astera Labs Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Earnings](https://longbridge.com/en/news/294963676.md)
- [Astera Labs Q2 FY26 GAAP net income more than doubles to $153.09 million; revenue more than doubles to $392.4 million](https://longbridge.com/en/news/294865977.md)
- [Astera Labs (ALAB) Is Up 6.7% After Strong AI Connectivity Expectations Ahead Of Q2 Earnings - Has The Bull Case Changed?](https://longbridge.com/en/news/294598674.md)
- [VectorGlobal IAG Inc. Acquires Shares of 13,236 Astera Labs, Inc. $ALAB](https://longbridge.com/en/news/294679172.md)